Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-02 · accession 0001209191-22-034170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-03 | 2022-06-02 | STOK | Tulipano Stephen J | CFO | M - OptEx | $4.48 | +11.2K | 11.8K | +1,854% | +$50.0K |
| D | 2022-06-03 | 2022-06-02 | STOK | Tulipano Stephen J | CFO | M - OptEx | $0.00 | -11.2K | 168.8K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-02 | M | A | 11,160 | $4.48 | 11,762 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-06-02 | M | D | 11,160 | $0.00 | 168,837 | D | $4.48 · — to 2029-03-18 | 11,160 Common Stock | (F1) The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. |